Infinity Pharmaceuticals Inc. (INFI)

1.24
0.02 1.64
NASDAQ : Health Technology
Prev Close 1.22
Open 1.22
Day Low/High 1.14 / 1.26
52 Wk Low/High 1.00 / 2.92
Volume 204.28K
Avg Volume 72.80K
Exchange NASDAQ
Shares Outstanding 57.03M
Market Cap 68.43M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Infinity To Present At The Goldman Sachs 35th Annual Global Healthcare Conference

Infinity To Present At The Goldman Sachs 35th Annual Global Healthcare Conference

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Goldman Sachs 35 th Annual Global Healthcare Conference on June 10, 2014, at 4:00 p.

'Fast Money' Recap: What's On? How About Netflix Stock?

'Fast Money' Recap: What's On? How About Netflix Stock?

The trading panel discussed Netflix's valuation and whether shares are worth buying.

Infinity To Participate In Four Conferences In June

Infinity To Participate In Four Conferences In June

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following four upcoming conferences: Jefferies 2014 Global Healthcare Conference, New York, June 3 rd, at 4:30 p.

Infinity Reports First Quarter 2014 Financial Results And Provides Company Update

Infinity Reports First Quarter 2014 Financial Results And Provides Company Update

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2014 financial results and ongoing progress with IPI-145, the company’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and ...

Infinity To Participate In 3 Upcoming Conferences

Infinity To Participate In 3 Upcoming Conferences

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following 3 upcoming conferences: Deutsche Bank 39 th Annual Health Care Conference – Boston, May 7 th, at 4:10 p.

RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold

RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Infinity Announces The Date Of Its First Quarter 2014 Financial Results Conference Call And Webcast

Infinity Announces The Date Of Its First Quarter 2014 Financial Results Conference Call And Webcast

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 6, 2014, at 4:30 p.

Infinity Pharmaceuticals Enters Oversold Territory (INFI)

Infinity Pharmaceuticals Enters Oversold Territory (INFI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors

Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has appointed José Baselga M.

Infinity To Present At The Upcoming Bernstein Emerging Biotech Conference

Infinity To Present At The Upcoming Bernstein Emerging Biotech Conference

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Bernstein Emerging Biotech Conference 2014 on Monday, March 10 th at 4:00 p.

Infinity Provides Company Update And Reports Full-Year 2013 Financial Results

Infinity Provides Company Update And Reports Full-Year 2013 Financial Results

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today its full-year 2013 financial results, a $100M debt facility and ongoing progress with IPI-145, the Company’s oral inhibitor of ...

Infinity To Participate In 3 Upcoming Conferences

Infinity To Participate In 3 Upcoming Conferences

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following 3 upcoming conferences: Citi 2014 Global Healthcare Conference – New York, February 26 th, 10:30 a.

Infinity Announces The Date Of Its Full-Year 2013 Financial Results Conference Call And Webcast

Infinity Announces The Date Of Its Full-Year 2013 Financial Results Conference Call And Webcast

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, February 25, 2014, at 8:30 a.

Infinity Announces Promotion Of David A. Roth To Chief Medical Officer

Infinity Announces Promotion Of David A. Roth To Chief Medical Officer

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the promotion of David A.

Infinity Reports Phase 1 Data Of IPI-145 At Sixth Annual T-Cell Lymphoma Forum

Infinity Reports Phase 1 Data Of IPI-145 At Sixth Annual T-Cell Lymphoma Forum

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported encouraging data from its ongoing Phase 1 study of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with...

Infinity Provides Key 2014 Goals And Financial Guidance

Infinity Provides Key 2014 Goals And Financial Guidance

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) today announced its anticipated pipeline goals and provided financial guidance for 2014.

Infinity To Present At J.P. Morgan Annual Healthcare Conference

Infinity To Present At J.P. Morgan Annual Healthcare Conference

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the J.

The Billion-Dollar Biotech Club: Speculation Trumped Risk

The Billion-Dollar Biotech Club: Speculation Trumped Risk

The list of biotech and drug stocks with billion-dollar market values almost doubled in 2013 -- a sign that investors loved speculation and were rewarded for it.

Why Investors Are Writing Off Infinity Pharma

Why Investors Are Writing Off Infinity Pharma

Infinity's B-cell malignancy drug is seen as too far behind competitors but can combination therapy make it more relevant?

Commit To Purchase Infinity Pharmaceuticals At $8, Earn 13.8% Using Options

Commit To Purchase Infinity Pharmaceuticals At $8, Earn 13.8% Using Options

Investors considering a purchase of Infinity Pharmaceuticals stock, but cautious about paying the going market price of $12.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $8 strike, which has a bid at the time of this writing of $1.10.

Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity Of IPI-145 In Chronic Lymphocytic Leukemia And T-Cell Lymphoma At ASH Annual Meeting

Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity Of IPI-145 In Chronic Lymphocytic Leukemia And T-Cell Lymphoma At ASH Annual Meeting

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) today announced updated data from a Phase 1 study of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with chronic...

Infinity Reports Updated Phase 1 Data Of IPI-145 In Indolent Non-Hodgkin Lymphoma At ASH Annual Meeting

Infinity Reports Updated Phase 1 Data Of IPI-145 In Indolent Non-Hodgkin Lymphoma At ASH Annual Meeting

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced updated Phase 1 data from an ongoing study of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with ...

Infinity Reports Preclinical Data At ASH Annual Meeting In Diffuse Large B-Cell Lymphoma And T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential Of IPI-145 In Blood Cancers

Infinity Reports Preclinical Data At ASH Annual Meeting In Diffuse Large B-Cell Lymphoma And T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential Of IPI-145 In Blood Cancers

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced new preclinical data showing the activity of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in models of diffuse...

Infinity To Present At The Oppenheimer 24th Annual Healthcare Conference

Infinity To Present At The Oppenheimer 24th Annual Healthcare Conference

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Oppenheimer 24th Annual Healthcare Conference on December 11, 2013, at 9:30 a.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

Infinity Announces New Date And Time For Credit Suisse 2013 Healthcare Conference Presentation And Webcast

Infinity Announces New Date And Time For Credit Suisse 2013 Healthcare Conference Presentation And Webcast

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that its presentation at the Credit Suisse 2013 Healthcare Conference, originally scheduled for November 13, 2013, has been rescheduled to November 12, ...

Infinity Reports Third Quarter 2013 Financial Results And Provides Company Update

Infinity Reports Third Quarter 2013 Financial Results And Provides Company Update

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its third quarter 2013 financial results and provided an update on its clinical pipeline.

Infinity Announces Clinical And Preclincial Data To Be Presented At ASH 2013 Annual Meeting

Infinity Announces Clinical And Preclincial Data To Be Presented At ASH 2013 Annual Meeting

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new data for IPI-145, the company’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at the American...

Infinity To Participate In Three Upcoming Conferences

Infinity To Participate In Three Upcoming Conferences

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in three upcoming investor conferences.

RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold

RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: D (Sell)